Variable | Tumor cells (64) | Stroma (64) | |||||
---|---|---|---|---|---|---|---|
Low (38) | High (22) | Unknown (4) | p-value | Low (27) | High (37) | p-value | |
Age | 63 (36–78) | 59 (42–79) | 66 (63–68) | 0.13 | 61 (36–74) | 62 (44–79) | 0.8 |
Gender | |||||||
M | 29 | 16 | 3 | 0.77 | 19 | 29 | 0.56 |
F | 9 | 6 | 1 | Â | 8 | 8 | Â |
Location | |||||||
Rab | 2 | 1 | Â | 0.69 | 2 | 1 | 0.48 |
Rb | 36 | 21 | Â | Â | 25 | 36 | Â |
Histology | |||||||
Differentiated | 32 | 20 | Â | 0.7 | 22 | 31 | 0.46 |
Undifferentiated | 6 | 2 | Â | Â | 2 | 6 | Â |
Lymphatic invasion | |||||||
Absent | 24 | 11 | Â | 0.42 | 17 | 22 | 0.8 |
Present | 14 | 11 | Â | Â | 10 | 15 | Â |
Venous invasion | |||||||
Absent | 13 | 9 | Â | 0.78 | 10 | 16 | 0.8 |
Present | 25 | 13 | Â | Â | 17 | 21 | Â |
Tumor Stage | |||||||
t0/t1 | 4 | 0 | 4 | 0.48 | 5 | 3 | 0.35 |
t2 | 9 | 5 | Â | Â | 7 | 7 | Â |
t3 | 23 | 14 | Â | Â | 12 | 25 | Â |
t4 | 2 | 3 | Â | Â | 3 | 2 | Â |
N stage | |||||||
n0 | 23 | 15 | Â | 0.59 | 17 | 25 | 0.79 |
n1< | 15 | 7 | Â | Â | 10 | 12 | Â |
Pathological response | |||||||
grade 0/1 | 25 | 17 | Â | 0.29 | 18 | 24 | 0.63 |
grade 2 | 13 | 5 | 1 | Â | 7 | 12 | Â |
grade 3 | 0 | 0 | 3 | Â | 2 | 1 | Â |
Combined Chemotherapy | |||||||
Not given | 3 | 4 | 0 | 0.31 | 4 | 3 | 0.2 |
Given | 35 | 18 | 4 | Â | 23 | 34 | Â |
Adjuvant chemotherapy | |||||||
Given | 16 | 5 | Â | 0.13 | 9 | 12 | 0.99 |
Not Given | 22 | 17 | 4 | Â | 18 | 25 | Â |
Recurrence | |||||||
Present | 11 | 11 | Â | 0.16 | 6 | 16 | 0.11 |
Absent | 27 | 11 | 4 | Â | 21 | 21 | Â |